Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
Long-term survival in unfavorable-risk mRCC patients treated with a combination of autologous immunotherapy (AGS-003) plus sunitinib.
Academic Article
Overview
Identity
Additional Document Info
View All
Overview
authors
Amin, Asim
Dudek, Arkadiusz Z.
Logan, Theodore F.
Lance, Raymond S.
Holzbeierlein, Jeffrey M.
Master, Viraj A.
Pal, Sumanta Kumar
Knox, Jennifer J.
Karsh, Lawrence, MD, FACS, CPI
Plessinger, Doug
Nicolette, Charles A.
Figlin, Robert A.
Publication Date
2014
webpage
http://dx.doi.org/10.1200/jco.2014.32.15_suppl.4524
published in
JOURNAL OF CLINICAL ONCOLOGY
Journal
Identity
Digital Object Identifier (DOI)
https://doi.org/10.1200/jco.2014.32.15_suppl.4524
Additional Document Info
number of pages
1
start page
4524
end page
4524
volume
32
issue
15_suppl